상세 보기
Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model
- Koh, Jiae;
- Kim, Sohyun;
- Lee, Sang Nam;
- Kim, Sun-Young;
- Kim, Jung-Eun;
- ... Sun, Jong-Mu;
- ... Lee, Se-Hoon;
- ... Ahn, Jin Seok;
- 외 10명
WEB OF SCIENCE
37SCOPUS
42초록
Although immune checkpoint inhibitors have significantly improved clinical outcomes in various malignant cancers, only a small proportion of patients reap benefits, likely due to the low number of T cells and high number of immunosuppressive cells in the tumor microenvironment (TME) of patients with advanced disease. We developed a cancer vaccine adjuvanted with nanoemulsion (NE) loaded with TLR7/8 agonist (R848) and analyzed its therapeutic effect alone or in combination with immune checkpoint inhibitors, on antitumor immune responses and the reprogramming of suppressive immune cells in the TME. NE (R848) demonstrated robust local and systemic antitumor immune responses in both subcutaneous and orthotopic mouse lung cancer models, inducing tumor-specific T cell activation and mitigating T cell exhaustion. Combination with anti-PD-1 antibodies showed synergistic effects with respect to therapeutic efficacy and survival rate. Thus, NE (R848)-based cancer vaccines could prevent tumor recurrence and prolong survival by activating antitumor immunity and reprogramming immunosuppression. (c) 2021 Elsevier Inc. All rights reserved.
키워드
- 제목
- Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model
- 저자
- Koh, Jiae; Kim, Sohyun; Lee, Sang Nam; Kim, Sun-Young; Kim, Jung-Eun; Lee, Kyoung Young; Kim, Mi Soon; Heo, Jae Yeong; Park, Young Mee; Ku, Bo Mi; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Yang, Siyoung; Ha, Sang-Jun; Lim, Yong Taik; Ahn, Myung-Ju
- 발행일
- 2021-10
- 유형
- Article
- 권
- 37
- 언어
- ENG
- 출판사
- Elsevier BV
- 발행국가
- 네덜란드
- ISSN
- E 1549-9642
P 1549-9634